Abstract
The present invention encompasses compounds of formula (I) wherein the groups R1, A, G, LK and t have the meanings given in the claims and specification, their use as degraders of SMARCA2 and/or SMARCA4, pharmaceutical compositions which contain compounds of this kind and their use as medicaments/medical uses, especially as agents for treatment and/or prevention of oncological diseases.
Original language | English |
---|---|
Patent number | WO/2020/078933 |
Priority date | 16/10/18 |
Filing date | 14/10/19 |
Publication status | Published - 23 Apr 2020 |